Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-248

NCT04036227 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: GS-248
DRUG: Placebo

Sponsor

Gesynta Pharma AB

Collaborators

[object Object]